Why I’m Buying and Holding Bionano Genomics (BNGO)

Bionano Genomics shares are trading higher on Friday 12th after the company tweeted about an upcoming event.

Bionano Genomics tweeted, “Beginner's Guide to Optical Genome Mapping: The Key to Structural Variation Detection. Dr. Sven Bocklandt, Vice President of Scientific Affairs at Bionano will walk through the basics of the technology and SV detection.”

BNGO is a life sciences instrumentation company in the genome analysis space. It‘s engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection, that enables researchers and clinicians to accelerate the search for new diagnostics targets, to streamline the study of changes in genes.

Bionano Genomics shares were trading up 18.03 percent at $13.81. The stock has a 52-week high of $14.44 and a 52-week low of $0.25.

We give BNGO a BUY rating with a 12 month Target price of $28.